Cas no 40267-72-9 (Ethyl Geranylether)
Ethyl Geranylether Chemical and Physical Properties
Names and Identifiers
-
- Ethyl geranyl ether
- Geranyl ethyl ether
- (2E)-1-Ethoxy-3,7-dimethylocta-2,6-diene
- 1-ethoxy-3,7-dimethyl-2,6-octadiene
- 1-ethoxy-3,7-dimethyl-6-octadiene
- 1-Ethoxy-3,7-dimethylocta-2,6-dien
- 1-ethoxy-3,7-dimethyl-octa-2,6-diene
- 3,7-Dimethyl-1-ethoxy-2,6-octadien
- 3,7-DIMETHYL-2,6-OCTADIEN-1-ETHOXY
- 6-Octadiene,1-ethoxy-3,7-dimethyl-2
- Ethyl geraniol
- NOVOROSAN
- Ethyl Geranylether
-
- Inchi: InChI=1S/C12H22O/c1-5-13-10-9-12(4)8-6-7-11(2)3/h7,9H,5-6,8,10H2,1-4H3/b12-9-
- InChI Key: LOUIMJFJROISMD-XFXZXTDPSA-N
- SMILES: C(OCC)/C=C(\CC/C=C(\C)/C)/C
Computed Properties
- Exact Mass: 182.16700
Experimental Properties
- Density: 0.8844 (rough estimate)
- Boiling Point: 255.73°C (rough estimate)
- Refractive Index: 1.5050 (estimate)
- PSA: 9.23000
- LogP: 3.71560
Ethyl Geranylether Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | E259065-50mg |
Ethyl Geranylether |
40267-72-9 | 50mg |
$155.00 | 2023-05-18 | ||
| TRC | E259065-100mg |
Ethyl geranylether |
40267-72-9 | 100mg |
335.00 | 2021-08-13 | ||
| TRC | E259065-250mg |
Ethyl Geranylether |
40267-72-9 | 250mg |
$689.00 | 2023-05-18 | ||
| TRC | E259065-500mg |
Ethyl Geranylether |
40267-72-9 | 500mg |
$ 1200.00 | 2023-09-07 | ||
| A2B Chem LLC | AF70078-100mg |
Ethyl geranyl ether |
40267-72-9 | 100mg |
$127.00 | 2024-04-20 | ||
| A2B Chem LLC | AF70078-500mg |
Ethyl geranyl ether |
40267-72-9 | 500mg |
$356.00 | 2024-04-20 | ||
| A2B Chem LLC | AF70078-1g |
Ethyl geranyl ether |
40267-72-9 | 1g |
$603.00 | 2024-04-20 | ||
| A2B Chem LLC | AF70078-5g |
Ethyl geranyl ether |
40267-72-9 | 5g |
$2233.00 | 2024-04-20 |
Ethyl Geranylether Related Literature
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
Additional information on Ethyl Geranylether
Ethyl Geranylether (CAS No. 40267-72-9): Applications and Research Insights
Ethyl Geranylether, chemically identified by the CAS number 40267-72-9, is an organic compound that has garnered significant attention in the field of organic chemistry and pharmaceutical research. This compound, featuring an ethyl group and a geranyl moiety, exhibits unique structural and functional properties that make it a valuable intermediate in synthetic chemistry and a potential candidate for various applications.
The molecular structure of Ethyl Geranylether consists of a geranyl group attached to an ethyl ether linkage. This configuration imparts flexibility and reactivity to the molecule, making it useful in the synthesis of more complex organic compounds. The geranyl unit, derived from geraniol, is well-known for its presence in essential oils and natural products, contributing to the compound's potential biological activity.
In recent years, Ethyl Geranylether has been studied for its role in the synthesis of terpenoids and other bioactive molecules. Terpenoids are a large class of naturally occurring compounds that exhibit a wide range of biological activities, including anti-inflammatory, antimicrobial, and antioxidant properties. The geranyl moiety in Ethyl Geranylether serves as a key building block in the construction of these terpenoid derivatives.
One of the most promising areas of research involving Ethyl Geranylether is its application in drug discovery and development. Researchers have explored its potential as a precursor in the synthesis of novel therapeutic agents. The compound's ability to undergo various chemical transformations allows for the creation of diverse molecular architectures, which can be tailored to target specific biological pathways.
Recent studies have highlighted the use of Ethyl Geranylether in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs are widely used for their pain-relieving and anti-inflammatory effects. The geranyl group in Ethyl Geranylether can be modified to introduce specific functional groups that enhance the pharmacological properties of the resulting NSAIDs. This approach has led to the development of several promising lead compounds that are currently under investigation.
Another area where Ethyl Geranylether has shown promise is in the field of agrochemicals. Terpenoids derived from geranyl-containing compounds have been found to possess insecticidal and fungicidal properties. Ethyl Geranylether can be used as an intermediate in the synthesis of these bioactive molecules, offering a sustainable and environmentally friendly alternative to traditional agrochemicals.
The chemical reactivity of Ethyl Geranylether also makes it a valuable tool in synthetic organic chemistry. The compound can undergo various reactions, including esterification, oxidation, and reduction, allowing chemists to construct complex molecules with precision. These synthetic capabilities have been leveraged in the development of new methodologies for constructing carbon-carbon bonds, which are essential in many organic transformations.
In conclusion, Ethyl Geranylether (CAS No. 40267-72-9) is a versatile compound with numerous applications in pharmaceuticals, agrochemicals, and synthetic chemistry. Its unique structural features and reactivity make it a valuable intermediate for the synthesis of bioactive molecules. As research continues to uncover new applications for this compound, its importance in chemical science is likely to grow even further.
40267-72-9 (Ethyl Geranylether) Related Products
- 15130-76-4(2,6,10-Dodecatriene,1-methoxy-3,7,11-trimethyl-)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)